🔗 Share this article

Texas Attorney General Ken Paxton is suing the producers of Tylenol, claiming the companies withheld safety concerns that the medication posed to pediatric neurological development.

This legal action follows four weeks after President Donald Trump promoted an unverified association between consuming Tylenol - alternatively called acetaminophen - while pregnant and autism spectrum disorder in offspring.

Paxton is suing J&J, which once produced the medication, the exclusive pain medication recommended for women during pregnancy, and the current manufacturer, which currently produces it.

In a official comment, he stated they "deceived the public by making money from suffering and promoting medication without regard for the risks."

Kenvue states there is lacking scientific proof connecting Tylenol to autism.

"These companies deceived for years, intentionally threatening countless individuals to increase profits," the attorney general, from the Republican party, said.

Kenvue stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the likely effects that could have on the welfare of women and children in America."

On its website, the company also stated it had "regularly reviewed the pertinent research and there is no credible data that indicates a verified association between using acetaminophen and autism spectrum disorder."

Groups speaking for doctors and medical practitioners agree.

ACOG has declared acetaminophen - the main ingredient in Tylenol - is a restricted selection for pregnant women to treat pain and elevated temperature, which can create significant medical dangers if not addressed.

"In multiple decades of studies on the utilization of paracetamol in gestation, zero credible investigations has conclusively proven that the consumption of acetaminophen in any stage of pregnancy leads to neurological conditions in young ones," the group commented.

The lawsuit cites recent announcements from the Trump administration in claiming the medication is reportedly hazardous.

In recent weeks, Trump generated worry from public health officials when he told pregnant women to "struggle intensely" not to take acetaminophen when unwell.

The FDA then issued a notice that doctors should think about restricting the use of Tylenol, while also declaring that "a direct connection" between the drug and autism spectrum disorder in minors has not been established.

Health Secretary RFK Jr, who oversees the FDA, had pledged in spring to initiate "a massive testing and research effort" that would establish the origin of autism in a limited time.

But specialists warned that discovering a unique factor of autism - thought by researchers to be the result of a intricate combination of genetic and environmental factors - would be difficult.

Autism is a form of lifelong neurodivergence and disability that influences how individuals perceive and relate to the surroundings, and is recognized using doctors' observations.

In his lawsuit, the attorney general - a Trump ally who is running for federal office - asserts the manufacturer and J&J "willfully ignored and tried to quiet the research" around acetaminophen and autism.

This legal action attempts to require the corporations "destroy any marketing or advertising" that asserts Tylenol is secure for women during pregnancy.

The court case echoes the concerns of a collection of parents of minors with autism and ADHD who sued the makers of Tylenol in 2022.

A federal judge dismissed the case, stating investigations from the parents' expert witnesses was lacking definitive proof.